An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

• Status: Completed
• Trial end date: 2016-05-12
• Target enrollment: 0
• Participant gender: Female

Summary

This post-marketing, multi-center prospective study will be conducted in a open-label, non-interventional setting, for women seeking fertility treatment and will describe morphokinetic de-selection parameters in human embryos.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ferring Pharmaceuticals
• Treatments: Menotropins

Criteria

Inclusion Criteria:

• Age 21-45 years

• In Vitro Fertilisation/Intra Cytoplasmic Sperm Injection treatment in long or short protocol

• Receiving follicle stimulation with Menopur 600/1200 IU